These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 25416598)
1. Prognostıc value of increased HER2 expression in cancers of pancreas and biliary tree. Ata A; Polat A; Serinsöz E; Sungur MA; Arican A Pathol Oncol Res; 2015 Jul; 21(3):831-8. PubMed ID: 25416598 [TBL] [Abstract][Full Text] [Related]
2. A comparative study of intraductal papillary neoplasia of the biliary tract and pancreas. Kloek JJ; van der Gaag NA; Erdogan D; Rauws EA; Busch OR; Gouma DJ; ten Kate FJ; van Gulik TM Hum Pathol; 2011 Jun; 42(6):824-32. PubMed ID: 21292296 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab. Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689 [TBL] [Abstract][Full Text] [Related]
4. Differences in c-fos gene product expression in cancers of the gall-bladder and biliary tract. Lee CS Pathol Int; 1996 Oct; 46(10):771-6. PubMed ID: 8916147 [TBL] [Abstract][Full Text] [Related]
5. Distribution and pathological features of pancreatic, ampullary, biliary and duodenal cancers resected with pancreaticoduodenectomy. Chandrasegaram MD; Chiam SC; Chen JW; Khalid A; Mittinty ML; Neo EL; Tan CP; Dolan PM; Brooke-Smith ME; Kanhere H; Worthley CS World J Surg Oncol; 2015 Feb; 13():85. PubMed ID: 25890023 [TBL] [Abstract][Full Text] [Related]
6. Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance. Fong D; Steurer M; Obrist P; Barbieri V; Margreiter R; Amberger A; Laimer K; Gastl G; Tzankov A; Spizzo G J Clin Pathol; 2008 Jan; 61(1):31-5. PubMed ID: 16775119 [TBL] [Abstract][Full Text] [Related]
7. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater. Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of geminin expression levels in Ki67-high subset of estrogen receptor-positive and HER2-negative breast cancers. Yagi T; Inoue N; Yanai A; Murase K; Imamura M; Miyagawa Y; Enomoto Y; Nishimukai A; Takatsuka Y; Hirota S; Akazawa K; Miyoshi Y Breast Cancer; 2016 Mar; 23(2):224-30. PubMed ID: 25082658 [TBL] [Abstract][Full Text] [Related]
9. Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013. Ehinger A; Malmström P; Bendahl PO; Elston CW; Falck AK; Forsare C; Grabau D; Rydén L; Stål O; Fernö M; Acta Oncol; 2017 Jan; 56(1):68-74. PubMed ID: 27762648 [TBL] [Abstract][Full Text] [Related]
10. Profile of HER2 +ve Gastric Cancers in Brunei Darussalam. Chong VH; Telisinghe PU; Tan J; Abdullah MS; Chong CF Asian Pac J Cancer Prev; 2016; 17(5):2555-8. PubMed ID: 27268629 [TBL] [Abstract][Full Text] [Related]
11. Moderate HER2 expression as a prognostic factor in hormone receptor positive breast cancer. Eggemann H; Ignatov T; Burger E; Kantelhardt EJ; Fettke F; Thomssen C; Costa SD; Ignatov A Endocr Relat Cancer; 2015 Oct; 22(5):725-33. PubMed ID: 26187126 [TBL] [Abstract][Full Text] [Related]
12. Relative Prognostic and Predictive Value of Gene Signature and Histologic Grade in Estrogen Receptor-Positive, HER2-Negative Breast Cancer. Iwamoto T; Kelly C; Mizoo T; Nogami T; Motoki T; Shien T; Taira N; Hayashi N; Niikura N; Fujiwara T; Doihara H; Matsuoka J Clin Breast Cancer; 2016 Apr; 16(2):95-100.e1. PubMed ID: 26631838 [TBL] [Abstract][Full Text] [Related]
13. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma. Sun J; Bi F; Yang Y; Zhang Y; Jin A; Li J; Lin Z Oncol Rep; 2017 Feb; 37(2):857-864. PubMed ID: 27959420 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of HER2/neu oncogene in pancreatic cancer correlates with shortened survival. Lei S; Appert HE; Nakata B; Domenico DR; Kim K; Howard JM Int J Pancreatol; 1995 Feb; 17(1):15-21. PubMed ID: 8568330 [TBL] [Abstract][Full Text] [Related]
15. Impact of age, intrinsic subtype and local treatment on long-term local-regional recurrence and breast cancer mortality among low-risk breast cancer patients. Laurberg T; Alsner J; Tramm T; Jensen V; Lyngholm CD; Christiansen PM; Overgaard J Acta Oncol; 2017 Jan; 56(1):59-67. PubMed ID: 27846764 [TBL] [Abstract][Full Text] [Related]
16. Impact of HER2 expression on outcome in gastric cancer patients with liver metastasis. Jiang H; Li Q; Yu S; Yu Y; Wang Y; Li W; Cui Y; Liu T Clin Transl Oncol; 2017 Feb; 19(2):197-203. PubMed ID: 27324991 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression and prognostic value of ER, PR and HER2/neu in pancreatic and small intestinal neuroendocrine tumors. Arnason T; Sapp HL; Barnes PJ; Drewniak M; Abdolell M; Rayson D Neuroendocrinology; 2011; 93(4):249-58. PubMed ID: 21487213 [TBL] [Abstract][Full Text] [Related]
18. T-complex-associated-testis-expressed 3 (TCTE3) is a novel marker for pancreatobiliary carcinomas. Zhao CL; Hui Y; Wang LJ; Lombardo K; Yang D; Mangray S; Yakirevich E; Amin A; Huang CK; Lu S Hum Pathol; 2017 Dec; 70():62-69. PubMed ID: 29079176 [TBL] [Abstract][Full Text] [Related]
19. Ki-67 is a prognostic marker for hormone receptor positive tumors. Pérez-López ME; García-Gómez J; Alves MT; Paradela A; García-Mata J; García-Caballero T Clin Transl Oncol; 2016 Oct; 18(10):996-1002. PubMed ID: 26742937 [TBL] [Abstract][Full Text] [Related]
20. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection]. Ridwelski K; Meyer F; Schmidt U; Lippert H Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]